THIS WEBSITE USES COOKIES
We use cookies to personalise content, to provide social media features, and to analyse our traffic. By choosing 'allow all cookies', you consent to our cookies.
To find out more, read our privacy policy and cookie policy.
My academic journey began with a strong interest in analytical chemistry and its applications in health and environmental sciences. I earned my Bachelor’s degree in Chemistry from the University of Ioannina, Greece, in 2020. After fulfilling my military service, I completed my Master’s degree at Aristotle University of Thessaloniki in 2024, specialising in bioanalysis and pharmaceutical analysis.
I gained practical experience as a member of Biomic_AUTH from September 2022 to December 2023, where I developed and validated a HILIC-MS/MS method for the determination of acylcarnitines in dried blood spots. I also contributed to additional projects, further enhancing my skills in advanced mass spectrometry and chromatography techniques. Alongside this, I expanded my knowledge through an Erasmus research assistant position at the Clinical Chemistry Laboratory, University of Liège, from January to June 2023. During this time, I assisted in developing analytical methods for quantifying parathyroid hormone (PTH), amino-PTH, and its fragments in plasma.
In the summer of 2023, I attended the Molecular Medicine Summer School at the University Hospital of Jena as a scholarship recipient, gaining invaluable insights into molecular medicine, bioinformatics, and analytical chemistry. After completing my thesis, I joined DEMO Pharmaceuticals in Thessaloniki in January 2023, where I worked throughout the year, focusing on the development and validation of HPLC methods for pharmaceutical applications.
As a MobiliTraIN doctoral candidate, my goal is to integrate ion mobility into non-targeted screening workflows to enhance safety, assess exposure risks, and advance public health. I look forward to exploring innovative, interdisciplinary solutions that combine my background with cutting-edge technologies to contribute to addressing health-related challenges.
Country: Belgium
Duration: 3 months
Purpose: Validation of CCS database using alternative analytical platform (DTIMS) in an academic environment
Country: Germany
Duration: 2 months
Purpose: Comprehensive evaluation of new LC-IM-HRMS methods with established LC-HRMS in a commercial NTS laboratory
Country: United Kingdom
Purpose: Validation of LC-DTIM-HRMS protocols on a different platform (TWIMS) and exploring GC-IM-HRMS